16.09 -0.82 (-4.92%)
GHDX
Stock Details
Last Trade:16.09 Change:-0.82 (-4.92%) Prev Close:16.91 Open: 16.68 Days Range:15.93 – 16.81 52 Week Range: 15.93 - 27.22 Volume:169269 P/E: N/AEPS:-0.50
View AllRecent Alerts 07/04/09
Recent Alert on 06/11/09 at 7:48am
Thomas Weisel Upgrades Genomic Health (GHDX) to Overweight
Thomas Weisel Upgrades Genomic Health (GHDX) to Overweight
Thomas Weisel upgrades Genomic Health (Nasdaq: GHDX) from Marketweight to Overweight. Price target $23. To see more analyst ratings on GHDX Click Here. Genomic Health, Inc., a life science company, engages in the development and commercialization of... Read More
Recent Alert on 05/15/09 at 9:43am
Morning Movers 5/15: XOMA, ADY, EXEL, DRYS, WX, LVS, HIG Higher; RGDX, TBAC, GU Lower
Morning Movers 5/15: XOMA, ADY, EXEL, DRYS, WX, LVS, HIG Higher; RGDX, TBAC, GU Lower
Recent Alert on 05/15/09 at 8:25am
Genomic Health's (GHDX) Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients
Genomic Health's (GHDX) Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients
Recent Alert on 05/15/09 at 8:25am
Genomic Health's (GHDX) Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients
Genomic Health's (GHDX) Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available